C. Abbosh, N. J. Birkbak, G. A. Wilson, M. Jamal-hanjani, T. Constantin et al., Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution, Nature, vol.545, pp.446-451, 2017.

C. Abou-faycal, E. Brambilla, J. Agorreta, N. Lepeltier, T. Jacquet et al., The sVEGFR1-i13 splice variant regulates a beta1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma, Br. J. Cancer, vol.118, pp.1596-1608, 2018.

C. Aguado, A. Gimenez-capitan, N. Karachaliou, A. Perez-rosado, S. Viteri et al., Fusion gene and splice variant analyses in liquid biopsies of lung cancer patients, Transl. Lung Cancer Res, vol.5, pp.525-531, 2016.

D. Aird, T. Teng, C. L. Huang, E. Pazolli, D. Banka et al., Sensitivity to splicing modulation of Bcl2 family genes defines cancer therapeutic strategies for splicing modulators, Nat. Commun, vol.10, p.137, 2019.

J. Alsarraj, R. C. Walker, J. D. Webster, T. R. Geiger, N. P. Crawford et al., Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition-and stem cell-like conversion, Cancer Res, vol.71, pp.3121-3131, 2011.

A. Amatu, A. Sartore-bianchi, and S. Siena, NTRK gene fusions as novel targets of cancer therapy across multiple tumour types, ESMO Open, vol.1, p.23, 2016.

E. S. Antonarakis, C. Lu, B. Luber, H. Wang, Y. Chen et al., Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer, JAMA Oncol, vol.1, pp.582-591, 2015.

E. S. Antonarakis, C. Lu, B. Luber, H. Wang, Y. Chen et al., Clinical significance of androgen receptor splice variant-7 mRNA detection in circulating tumor cells of men with metastatic castration-resistant prostate cancer treated with first-and second-line abiraterone and enzalutamide, J. Clin. Oncol, vol.35, pp.2149-2156, 2017.

E. S. Antonarakis, C. Lu, H. Wang, B. Luber, M. Nakazawa et al., AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer, N. Engl. J. Med, vol.371, pp.1028-1038, 2014.

K. S. Anufrieva, O. Shender-vcapital, G. P. Arapidi, M. S. Pavlyukov, M. I. Shakhparonov et al., Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells, Genome Med, vol.10, p.49, 2018.

S. Araki, R. Dairiki, Y. Nakayama, A. Murai, R. Miyashita et al., Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing, PLoS One, vol.10, p.116929, 2015.

R. Ashwal-fluss, M. Meyer, N. R. Pamudurti, A. Ivanov, O. Bartok et al., Circrna biogenesis competes with pre-mRNA splicing, Mol. Cell, vol.56, pp.55-66, 2014.

J. H. Bahn, Q. Zhang, F. Li, T. M. Chan, X. Lin et al., The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva, Clin. Chem, vol.61, pp.221-230, 2015.

D. Barbagallo, A. Caponnetto, M. Cirnigliaro, D. Brex, C. Barbagallo et al., CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB, Int. J. Mol. Sci, vol.19, p.480, 2018.

J. A. Bauman, S. D. Li, A. Yang, L. Huang, and R. Kole, Anti-tumor activity of splice-switching oligonucleotides, Nucleic Acids Res, vol.38, pp.8348-8356, 2010.

N. Beije, A. M. Sieuwerts, J. Kraan, N. M. Van, W. Onstenk et al., Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients, Mol. Oncol, vol.12, pp.48-57, 2018.

E. Berman, S. Jhanwar, C. Hedvat, M. E. Arcila, O. A. Wahab et al., Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS), Leuk Res, vol.49, pp.108-112, 2016.

M. G. Best, N. Sol, I. Kooi, J. Tannous, B. A. Westerman et al., RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics, Cancer Cell, vol.28, pp.666-676, 2015.

A. Boudria, C. Abou-faycal, T. Jia, S. Gout, M. Keramidas et al., VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a beta1 integrin/VEGFR autocrine loop, Oncogene, vol.38, pp.1050-1066, 2018.

W. Cai, D. Lin, C. Wu, X. Li, C. Zhao et al., Intratumoral heterogeneity of ALK-rearranged and ALK/EGFR coaltered lung adenocarcinoma, J. Clin. Oncol, vol.33, pp.3701-3709, 2015.

B. Chabot and L. Shkreta, Defective control of pre-messenger RNA splicing in human disease, J. Cell. Biol, vol.212, pp.13-27, 2016.

S. Chan, P. Sridhar, R. Kirchner, Y. J. Lock, Z. Herbert et al., Basal-A triple-negative breast cancer cells selectively rely on RNA splicing for survival, Mol. Cancer Ther, vol.16, pp.2849-2861, 2017.

K. Chansky, F. C. Detterbeck, A. G. Nicholson, V. W. Rusch, E. Vallieres et al., Staging, iaslc, prognostic factors committee, advisory boards, and participating, institutionsthe iaslc lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM Classification of Lung Cancer, J. Thorac. Oncol, vol.12, pp.1109-1121, 2017.

C. Y. Chen and P. Sarnow, Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs, Science, vol.268, pp.415-417, 1995.

D. Chen, W. Ma, Z. Ke, and F. Xie, CircRNA hsa_circ_100395 regulates mIR-1228/TCF21 pathway to inhibit lung cancer progression, Cell Cycle, vol.17, pp.2080-2090, 2018.

S. Chen, V. Huang, X. Xu, J. Livingstone, F. Soares et al., Widespread and functional RNA circularization in localized prostate cancer, Cell, vol.176, pp.22-843, 2019.

S. Cheng, J. Zheng, J. Zhu, C. Xie, X. Zhang et al., PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer, Int. J. Biol. Markers, vol.30, pp.364-368, 2015.

S. J. Conn, K. A. Pillman, J. Toubia, V. M. Conn, M. Salmanidis et al., The RNA binding protein quaking regulates formation of circRNAs, Cell, vol.160, pp.1125-1134, 2015.

M. Dewaele, T. Tabaglio, K. Willekens, M. Bezzi, S. X. Teo et al., Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth, J. Clin. Invest, vol.126, pp.68-84, 2016.

X. Ding, S. Zhang, X. Li, C. Feng, Q. Huang et al., Profiling expression of coding genes, long noncoding RNA, and circular RNA in lung adenocarcinoma by ribosomal RNA-depleted RNA sequencing, FEBS Open Bio, vol.8, pp.544-555, 2018.

Y. Dou, D. J. Cha, J. L. Franklin, J. N. Higginbotham, D. K. Jeppesen et al., Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes, Sci. Rep, vol.6, p.37982, 2016.

M. Dragomir and G. A. Calin, Circular RNAs in cancer-lessons learned from microRNAs, Front. Oncol, vol.8, p.179, 2018.

W. W. Du, W. Yang, Y. Chen, Z. K. Wu, F. S. Foster et al., Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses, Eur. Heart J, vol.38, pp.1402-1412, 2017.

R. A. Dubin, M. A. Kazmi, and H. Ostrer, Inverted repeats are necessary for circularization of the mouse testis Sry transcript, Gene, vol.167, pp.245-248, 1995.

V. Edmond, C. Brambilla, E. Brambilla, S. Gazzeri, and B. Eymin, Srsf2 is required for sodium butyrate-mediated P21(Waf1) induction and premature senescence in human lung carcinoma cell lines, Cell Cycle, vol.10, 1968.
URL : https://hal.archives-ouvertes.fr/inserm-02337383

Y. Enuka, M. Lauriola, M. E. Feldman, A. Sas-chen, I. Ulitsky et al., Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor, Nucleic Acids Res, vol.44, pp.1370-1383, 2016.

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012, Int. J. Cancer, vol.136, pp.359-386, 2015.

G. M. Frampton, S. M. Ali, M. Rosenzweig, J. Chmielecki, X. Lu et al., Activation of Met via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors, Cancer Discov, vol.5, pp.850-859, 2015.

T. Fukuhara, T. Hosoya, S. Shimizu, K. Sumi, T. Oshiro et al., Utilization of host SR protein kinases and RNA-splicing machinery during viral replication, Proc. Natl. Acad. Sci. U.S.A, vol.103, pp.11329-11333, 2006.

Q. Gou, K. Wu, J. K. Zhou, Y. Xie, L. Liu et al., Profiling and bioinformatic analysis of circular RNA expression regulated by c-Myc, Oncotarget, vol.8, pp.71587-71596, 2017.

S. Gout, E. Brambilla, A. Boudria, R. Drissi, S. Lantuejoul et al., Abnormal expression of the pre-mRNA splicing regulators Srsf1, Srsf2, Srpk1 and Srpk2 in non small cell lung carcinoma, PLoS One, vol.7, p.46539, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02337424

X. Gu, G. Wang, H. Shen, and X. Fei, Hsa_Circ_0033155: a potential novel biomarker for non-small cell lung cancer, Exp. Ther. Med, vol.16, pp.3220-3226, 2018.

J. Guarnerio, M. Bezzi, J. C. Jeong, S. V. Paffenholz, K. Berry et al., Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations, Cell, vol.166, pp.1055-1056, 2016.

J. U. Guo, V. Agarwal, H. Guo, and D. P. Bartel, Expanded identification and characterization of mammalian circular RNAs, Genome Biol, vol.15, p.409, 2014.

M. Hallegger, M. Llorian, and C. W. Smith, Alternative splicing: global insights, FEBS J, vol.277, pp.856-866, 2010.

J. Han, G. Zhao, X. Ma, Q. Dong, H. Zhang et al., CircRNA circ-BANP-mediated mIR-503/Larp1 signaling contributes to lung cancer progression, Biochem. Biophys. Res. Commun, vol.503, pp.2429-2435, 2018.

T. B. Hansen, T. I. Jensen, B. H. Clausen, J. B. Bramsen, B. Finsen et al., Natural RNA circles function as efficient microRNA sponges, Nature, vol.495, pp.384-388, 2013.

X. H. He, L. H. Xu, and Y. Liu, Identification of a novel splice variant of human PD-L1 mRNA encoding an isoform-lacking IgV-like domain, Acta Pharmacol. Sin, vol.26, pp.462-468, 2005.

N. L. Henry and D. F. Hayes, Cancer biomarkers, Mol. Oncol, vol.6, pp.140-146, 2012.

M. W. Hentze and T. Preiss, Circular RNAs: splicing's enigma variations, EMBO J, vol.32, pp.923-925, 2013.

L. A. Hepburn, A. Mchugh, K. Fernandes, G. Boag, C. M. Proby et al., Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type P53 in determining the degree of tumour selectivity, Oncotarget, vol.9, pp.23029-23046, 2018.

W. Hu, Z. Y. Bi, Z. L. Chen, C. Liu, L. L. Li et al., Emerging landscape of circular RNAs in lung cancer, Cancer Lett, vol.427, pp.18-27, 2018.

W. R. Jeck and N. E. Sharpless, Detecting and characterizing circular RNAs, Nat. Biotechnol, vol.32, pp.453-461, 2014.

W. R. Jeck, J. A. Sorrentino, K. Wang, M. K. Slevin, C. E. Burd et al., Circular RNAs are abundant, conserved, and associated with Alu repeats, RNA, vol.19, pp.141-157, 2013.

M. M. Jiang, Z. T. Mai, S. Z. Wan, Y. M. Chi, X. Zhang et al., Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis, J. Cancer Res. Clin. Oncol, vol.144, pp.667-674, 2018.

S. A. Joosse and K. Pantel, Tumor-educated platelets as liquid biopsy in cancer patients, Cancer Cell, vol.28, pp.552-554, 2015.

R. Katayama, A. T. Shaw, T. M. Khan, M. Mino-kenudson, B. J. Solomon et al., Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers, Sci. Transl. Med, vol.4, pp.120-137, 2012.

S. Kelly, C. Greenman, P. R. Cook, and A. Papantonis, Exon skipping is correlated with exon circularization, J. Mol. Biol, vol.427, pp.2414-2417, 2015.

M. Kong-beltran, S. Seshagiri, J. Zha, W. Zhu, K. Bhawe et al., Somatic mutations lead to an oncogenic deletion of met in lung cancer, Cancer Res, vol.66, pp.283-289, 2006.

M. S. Kopreski, F. A. Benko, L. W. Kwak, and C. D. Gocke, Detection of tumor messenger RNA in the serum of patients with malignant melanoma, Clin. Cancer Res, vol.5, pp.1961-1965, 1999.

M. C. Kramer, D. Liang, D. C. Tatomer, B. Gold, Z. M. March et al., Combinatorial control of Drosophila circular RNA expression by intronic repeats, Hnrnps, and Sr proteins, Genes Dev, vol.29, pp.2168-2182, 2015.

M. G. Kris, L. E. Gaspar, J. E. Chaft, E. B. Kennedy, C. G. Azzoli et al., Adjuvant systemic therapy and adjuvant radiation therapy for stage I to Iiia completely resected non-small-cell lung cancers, J. Clin. Oncol, vol.35, pp.2960-2974, 2017.

S. C. Lee and O. Wahab, Therapeutic targeting of splicing in cancer, Nat. Med, vol.22, pp.976-986, 2016.

S. C. Lee, H. Dvinge, E. Kim, H. Cho, J. B. Micol et al., Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins, Nat. Med, vol.22, pp.672-678, 2016.

I. Legnini, G. Di-timoteo, F. Rossi, M. Morlando, F. Briganti et al., Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis, Mol. Cell, vol.66, pp.9-37, 2017.

S. A. Leon, B. Shapiro, D. M. Sklaroff, Y. , and M. J. , Free DNA in the serum of cancer patients and the effect of therapy, Cancer Res, vol.37, pp.646-650, 1977.

L. Li, W. Li, N. Chen, H. Zhao, G. Xu et al., Fli1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer, Clin. Cancer Res, vol.25, pp.1302-1317, 2018.

S. Li, X. Sun, S. Miao, T. Lu, Y. Wang et al., Hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma, Thorac. Cancer, vol.9, pp.924-930, 2018.

S. Li, S. Teng, J. Xu, G. Su, Y. Zhang et al., Microarray is an efficient tool for circRNA profiling, Brief Bioinform, 2018.

Y. Li, J. Hu, L. Li, S. Cai, H. Zhang et al., Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through mIR-1287/GAGE1 axis, Biochem. Biophys. Res. Commun, vol.503, pp.2089-2094, 2018.

Y. Li, Q. Zheng, C. Bao, S. Li, W. Guo et al., Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis, Cell Res, vol.25, pp.981-984, 2015.

D. Liang and J. E. Wilusz, Short intronic repeat sequences facilitate circular RNA production, Genes Dev, vol.28, pp.2233-2247, 2014.

D. Liang, D. C. Tatomer, Z. Luo, H. Wu, L. Yang et al., The output of protein-coding genes shifts to circular RNAs when the pre-mRNA processing machinery is limiting, Mol. Cell, vol.68, pp.3-954, 2017.

W. Liu, W. Ma, Y. Yuan, Y. Zhang, and S. Sun, Circular RNA hsa_circRNA_103809 promotes lung cancer progression via facilitating ZNF121-dependent MYC expression by sequestering mIR-4302, Biochem. Biophys. Res. Commun, vol.500, pp.846-851, 2018.

Y. C. Liu, J. R. Li, C. H. Sun, E. Andrews, R. F. Chao et al., Circnet: a database of circular RNAs derived from transcriptome sequencing data, Nucleic Acids Res, vol.44, pp.209-215, 2016.

G. Lo-russo, M. Moro, M. Sommariva, V. Cancila, M. Boeri et al., Antibody-Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non-small cell lung cancer subsequent to PD-1/PD-L1 blockade, Clin. Cancer Res, vol.25, pp.989-999, 2018.

Y. H. Luo, X. Z. Zhu, K. W. Huang, Q. Zhang, Y. X. Fan et al., Emerging roles of circular RNA hsa_circ_0000064 in the proliferation and metastasis of lung cancer, Biomed. Pharmacother, vol.96, pp.892-898, 2017.

P. C. Ma, T. Kijima, G. Maulik, E. A. Fox, M. Sattler et al., c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions, Cancer Res, vol.63, pp.6272-6281, 2003.

X. Ma, X. Yang, W. Bao, S. Li, S. Liang et al., Circular RNA circMAN2B2 facilitates lung cancer cell proliferation and invasion via mIR-1275/FOXK1 axis, Biochem. Biophys. Res. Commun, vol.498, pp.1009-1015, 2018.

Y. Ma, X. Zhang, Y. Z. Wang, H. Tian, and S. Xu, Research progress of circular RNAs in lung cancer, Cancer Biol. Ther, vol.20, pp.123-129, 2018.

P. G. Maass, P. Glazar, S. Memczak, G. Dittmar, I. Hollfinger et al., A map of human circular RNAs in clinically relevant tissues, J. Mol. Med. (Berl.), vol.95, pp.1179-1189, 2017.

A. Mavrou, K. Brakspear, M. Hamdollah-zadeh, G. Damodaran, R. Babaei-jadidi et al., Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer, Oncogene, vol.34, pp.4311-4319, 2015.

S. Memczak, M. Jens, A. Elefsinioti, F. Torti, J. Krueger et al., Circular RNAs are a large class of animal RNAs with regulatory potency, Nature, vol.495, pp.333-338, 2013.

S. Memczak, P. Papavasileiou, O. Peters, and N. Rajewsky, Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood, PLoS One, vol.10, p.141214, 2015.

X. Meng, Y. Liu, J. Zhang, F. Teng, L. Xing et al., PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: new development and challenges, Cancer Lett, vol.405, pp.29-37, 2017.

S. Meyer, A. Stevens, R. Paredes, M. Schneider, M. J. Walker et al., Acquired cross-linker resistance associated with a novel spliced Brca2 protein variant for molecular phenotyping of BRCA2 disruption, Cell Death Dis, vol.8, p.2875, 2017.

T. Nakagawa, S. Takeuchi, T. Yamada, H. Ebi, T. Sano et al., EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition, Cancer Res, vol.73, pp.2428-2434, 2013.

P. V. Nazarov, A. Muller, T. Kaoma, N. Nicot, C. Maximo et al., RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples, BMC Genomics, vol.18, p.443, 2017.

K. P. Ng, A. M. Hillmer, C. T. Chuah, W. C. Juan, T. K. Ko et al., A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer, Nat. Med, vol.18, pp.521-528, 2012.

C. Nielsen, L. Ohm-laursen, T. Barington, S. Husby, and S. T. Lillevang, Alternative splice variants of the human PD-1 gene, Cell Immunol, vol.235, pp.109-116, 2005.

G. Nigita, M. Acunzo, W. C. Cho, and C. M. Croce, Editorial: epitranscriptomics: the novel RNA frontier, Front. Bioeng. Biotechnol, vol.6, p.191, 2018.

R. J. Nilsson, N. Karachaliou, J. Berenguer, A. Gimenez-capitan, P. Schellen et al., Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer, Oncotarget, vol.7, pp.1066-1075, 2016.

R. Obermannova, M. Redova-lojova, P. Vychytilova-faltejskova, P. Grell, W. C. Cho et al., Tumor expression of miR-10b, miR-21, miR-143 and miR-145 is related to clinicopathological features of gastric cancer in a central European population, Anticancer Res, vol.38, pp.3719-3724, 2018.

Y. Okuma, Y. Hosomi, Y. Nakahara, K. Watanabe, Y. Sagawa et al., High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer, Lung Cancer, vol.104, pp.1-6, 2017.

R. Onozato, T. Kosaka, H. Kuwano, Y. Sekido, Y. Yatabe et al., Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers, J. Thorac. Oncol, vol.4, pp.5-11, 2009.

W. Onstenk, A. M. Sieuwerts, J. Kraan, M. Van, A. J. Nieuweboer et al., Efficacy of cabazitaxel in castration-resistant prostate cancer is independent of the presence of AR-V7 in circulating tumor cells, Eur. Urol, vol.68, pp.939-945, 2015.

G. R. Oxnard, K. S. Thress, R. S. Alden, R. Lawrance, C. P. Paweletz et al., Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer, J. Clin. Oncol, vol.34, pp.3375-3382, 2016.

P. K. Paik, A. Drilon, P. D. Fan, H. Yu, N. Rekhtman et al., Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping, Cancer Discov, vol.5, pp.842-849, 2015.

N. R. Pamudurti, O. Bartok, M. Jens, R. Ashwal-fluss, C. Stottmeister et al., Translation of circRNAs, Mol. Cell, vol.66, pp.7-21, 2017.

Q. Pan, O. Shai, L. J. Lee, B. J. Frey, and B. J. Blencowe, Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing, Nat. Genet, vol.40, pp.1413-1415, 2008.

A. C. Panda, I. Grammatikakis, K. M. Kim, S. De, J. L. Martindale et al., Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1, Nucleic Acids Res, vol.45, pp.4021-4035, 2017.

R. Pio and L. M. Montuenga, Alternative splicing in lung cancer, J. Thorac. Oncol, vol.4, pp.674-678, 2009.

I. Poola and V. Speirs, Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues, J. Steroid Biochem. Mol. Biol, vol.78, pp.459-469, 2001.

P. I. Poulikakos, Y. Persaud, M. Janakiraman, X. Kong, C. Ng et al., RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E), Nature, vol.480, pp.387-390, 2011.

B. Q. Qiu, P. F. Zhang, D. Xiong, J. J. Xu, X. Long et al., CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling, J. Cell Physiol, vol.234, pp.11256-11264, 2018.

M. Qiu, W. Xia, R. Chen, S. Wang, Y. Xu et al., The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma, Cancer Res, vol.78, pp.2839-2851, 2018.

D. Qu, B. Yan, R. Xin, and T. Ma, A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of mIR-144 in non-small cell lung cancer, Am. J. Cancer Res, vol.8, pp.1387-1402, 2018.

L. E. Raez, P. Manca, C. Rolfo, and V. Singh, Ros-1 rearrangements in circulating tumor cells, J. Thorac. Oncol, vol.13, pp.71-72, 2018.

P. Reclusa, S. Taverna, M. Pucci, E. Durendez, S. Calabuig et al., Exosomes as dagnostic and predictive biomarkers in lung cancer, J. Thorac. Dis, vol.9, pp.1373-1382, 2017.

C. Rolfo, P. C. Mack, G. V. Scagliotti, P. Baas, F. Barlesi et al., Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the Iaslc, J. Thorac. Oncol, vol.13, pp.1248-1268, 2018.

J. P. Romero, M. Ortiz-estevez, A. Muniategui, S. Carrancio, F. J. De-miguel et al., Comparison of RNA-Seq and microarray platforms for splice event detection using a cross-platform algorithm, BMC Genomics, vol.19, p.703, 2018.

K. Sahadevan, S. Darby, H. Y. Leung, M. E. Mathers, C. N. Robson et al., Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer, J. Pathol, vol.213, pp.82-90, 2007.

M. Salton and T. Misteli, Small molecule modulators of pre-mRNA splicing in cancer therapy, Trends Mol. Med, vol.22, pp.28-37, 2016.

M. Salton, W. K. Kasprzak, T. Voss, B. A. Shapiro, P. I. Poulikakos et al., Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing, Nat. Commun, vol.6, p.7103, 2015.

J. Salzman, R. E. Chen, M. N. Olsen, P. L. Wang, and P. O. Brown, Cell-type specific features of circular RNA expression, PLoS Genet, vol.9, p.1003777, 2013.

J. Salzman, C. Gawad, P. L. Wang, N. Lacayo, and P. O. Brown, Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types, PLoS One, vol.7, p.30733, 2012.

T. Schneider, L. H. Hung, S. Schreiner, S. Starke, H. Eckhof et al., CircRNA-protein complexes: IMP3 protein component defines subfamily of, Circrnps. Sci. Rep, vol.6, p.31313, 2016.

M. Seiler, A. Yoshimi, R. Darman, B. Chan, G. Keaney et al., H3b-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers, Nat. Med, vol.24, pp.497-504, 2018.

A. K. Seitz, S. Thoene, A. Bietenbeck, R. Nawroth, R. Tauber et al., AR-V7 in peripheral whole blood of patients with castration-resistant prostate cancer: association with treatment-specific outcome under abiraterone and enzalutamide, Eur. Urol, vol.72, pp.828-834, 2017.

A. T. Shaw, D. W. Kim, K. Nakagawa, T. Seto, L. Crino et al., Crizotinib versus chemotherapy in advanced ALK-positive lung cancer, N. Engl. J. Med, vol.368, pp.2385-2394, 2013.

A. T. Shaw, B. Y. Yeap, B. J. Solomon, G. J. Riely, J. Gainor et al., Effect of crizotinib on overall survival in patients with advanced nonsmall-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis, Lancet Oncol, vol.12, pp.1004-1012, 2011.

J. Sheng, Q. Zhao, J. Zhao, W. Zhang, Y. Sun et al., SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance, EBioMedicine, vol.38, pp.113-126, 2018.

L. Shi, B. Dong, Z. Li, Y. Lu, T. Ouyang et al., Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer, J. Clin. Oncol, vol.27, pp.3423-3429, 2009.

R. L. Siegel, K. D. Miller, J. , and A. , Cancer statistics, vol.67, pp.7-30, 2017.

Z. Siegfried and R. Karni, The role of alternative splicing in cancer drug resistance, Curr. Opin. Genet. Dev, vol.48, pp.16-21, 2018.

R. P. Siqueira, A. Barbosa-ede, M. D. Poleto, G. L. Righetto, T. V. Seraphim et al., Potential antileukemia effect and structural analyses of SRPK inhibition by N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl)isonicotinamide (SRPIN340), PLoS One, vol.10, p.134882, 2015.

G. Siravegna, S. Marsoni, S. Siena, and A. Bardelli, Integrating liquid biopsies into the management of cancer, Nat. Rev. Clin. Oncol, vol.14, pp.531-548, 2017.

S. F. Sorensen, C. Demuth, B. Weber, B. S. Sorensen, and P. Meldgaard, Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib, Lung Cancer, vol.100, pp.77-84, 2016.

E. Sotillo, D. M. Barrett, K. L. Black, A. Bagashev, D. Oldridge et al., Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy, Cancer Discov, vol.5, pp.1282-1295, 2015.

S. Stamm, S. Ben-ari, I. Rafalska, Y. Tang, Z. Zhang et al., Function of alternative splicing, Gene, vol.344, pp.1-20, 2005.

K. Suda, L. Rozeboom, H. Yu, K. Ellison, C. J. Rivard et al., Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status, PLoS One, vol.12, p.172209, 2017.

D. C. Syafrizayanti, Q. Zhang, Y. Chen, Y. Wang, X. Zhang et al., Function, clinical application, and strategies of pre-mRNA splicing in cancer, Cell Death Differ, 2018.

L. Szabo and J. Salzman, Detecting circular RNAs: bioinformatic and experimental challenges, Nat. Rev. Genet, vol.17, pp.679-692, 2016.

S. Tan, D. Sun, W. Pu, Q. Gou, C. Guo et al., Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer, Mol. Cancer, vol.17, p.138, 2018.

Y. Tay, J. Rinn, and P. P. Pandolfi, The multilayered complexity of ceRNA crosstalk and competition, Nature, vol.505, pp.344-352, 2014.

J. K. Taylor, Q. Q. Zhang, J. R. Wyatt, and N. M. Dean, Induction of endogenous Bcl-Xs through the control of Bcl-X pre-mRNA splicing by antisense oligonucleotides, Nat. Biotechnol, vol.17, pp.1097-1100, 1999.

E. Ten-hacken, R. Valentin, F. F. Regis, J. Sun, S. Yin et al., Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies, JCI Insight, vol.3, p.121438, 2018.

F. Tian, C. T. Yu, W. D. Ye, W. , and Q. , Cinnamaldehyde induces cell apoptosis mediated by a novel circular RNA hsa_circ_0043256 in nonsmall cell lung cancer, Biochem. Biophys. Res. Commun, vol.493, pp.1260-1266, 2017.

K. Tzelepis, E. De-braekeleer, D. Aspris, I. Barbieri, M. S. Vijayabaskar et al., SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4, Nat. Commun, vol.9, p.5378, 2018.

K. Tzelepis, H. Koike-yusa, E. De-braekeleer, Y. Li, E. Metzakopian et al., A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia, Cell Rep, vol.17, pp.1193-1205, 2016.

A. Vaishnavi, M. Capelletti, A. T. Le, S. Kako, M. Butaney et al., Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer, Nat. Med, vol.19, pp.1469-1472, 2013.

W. Van-roosmalen, S. E. Le-devedec, O. Golani, M. Smid, I. Pulyakhina et al., Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant, J. Clin. Invest, vol.125, pp.1648-1664, 2015.

L. Wan, L. Zhang, K. Fan, Z. X. Cheng, Q. C. Sun et al., Circular RNA-ITCH suppresses lung cancer proliferation via inhibiting the Wnt/beta-catenin pathway, Biomed. Res. Int, p.1579490, 2016.

B. D. Wang and N. H. Lee, Aberrant RNA splicing in cancer and drug resistance, Cancers (Basel.), vol.10, p.458, 2018.

E. T. Wang, R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang et al., Alternative isoform regulation in human tissue transcriptomes, Nature, vol.456, pp.470-476, 2008.

F. Wang, A. J. Nazarali, J. , and S. , Circular RNAs as potential biomarkers for cancer diagnosis and therapy, Am. J. Cancer Res, vol.6, pp.1167-1176, 2016.

J. Wang, L. , and H. , CircRNA circ_0067934 silencing inhibits the proliferation, migration and invasion of NSCLC cells and correlates with unfavorable prognosis in NSCLC, Eur. Rev. Med. Pharmacol. Sci, vol.22, pp.3053-3060, 2018.

J. Wang, M. Zhu, J. Pan, C. Chen, S. Xia et al., Circular RNAs: a rising star in respiratory diseases, Respir Res, vol.20, p.3, 2019.

L. Wang, X. Tong, Z. Zhou, S. Wang, Z. Lei et al., Circular RNA hsa_circ_0008305 (CircPTK2) inhibits TGF-beta-induced epithelialmesenchymal transition and metastasis by controlling TIF1gamma in nonsmall cell lung cancer, Mol. Cancer, vol.17, p.140, 2018.

X. Wang, X. Zhu, H. Zhang, S. Wei, Y. Chen et al., Increased circular RNA hsa_circ_0012673 acts as a sponge of mIR-22 to promote lung adenocarcinoma proliferation, Biochem. Biophys. Res. Commun, vol.496, pp.1069-1075, 2018.

Y. Wang, A. J. Bernhardy, C. Cruz, J. J. Krais, J. Nacson et al., The BRCA1-Delta11q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin, Cancer Res, vol.76, pp.2778-2790, 2016.

Y. Wang, J. L. Dean, E. K. Millar, T. H. Tran, C. M. Mcneil et al., Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists, Cancer Res, vol.68, pp.5628-5638, 2008.

N. Xu, S. Chen, Y. Liu, W. Li, Z. Liu et al., Profiles and bioinformatics analysis of differentially expressed circRNAs in taxol-resistant non-small cell lung cancer cells, Cell Physiol. Biochem, vol.48, pp.2046-2060, 2018.

B. Yan, W. Zhang, X. W. Mao, and L. Y. Jiang, Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer, Eur. Rev. Med. Pharmacol. Sci, vol.22, pp.8712-8721, 2018.

J. T. Yao, S. H. Zhao, Q. P. Liu, M. Q. Lv, D. X. Zhou et al., Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value, Pathol. Res. Pract, vol.213, pp.453-456, 2017.

T. Yuan, X. Huang, M. Woodcock, M. Du, R. Dittmar et al., Plasma extracellular RNA profiles in healthy and cancer patients, Sci. Rep, vol.6, 2016.

P. G. Zaphiropoulos, Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis, Mol. Cell. Biol, vol.17, pp.2985-2993, 1997.

J. Zhang, J. Gao, Y. Li, J. Nie, L. Dai et al., Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics, Thorac. Cancer, vol.6, pp.534-538, 2015.

S. Zhang, X. Zeng, T. Ding, L. Guo, Y. Li et al., Microarray profile of circular RNAs identifies hsa_circ_0014130 as a new circular RNA biomarker in non-small cell lung cancer, Sci. Rep, vol.8, p.2878, 2018.

X. O. Zhang, H. B. Wang, Y. Zhang, X. Lu, L. L. Chen et al., Complementary sequence-mediated exon circularization, Cell, vol.159, pp.134-147, 2014.

Y. Zhang, H. Zhao, and L. Zhang, Identification of the tumor-suppressive function of circular RNA FOXO3 in nonsmall cell lung cancer through sponging mIR-155, Mol. Med. Rep, vol.17, pp.7692-7700, 2018.

C. Zhao, X. Li, J. Li, Y. Zhang, S. Ren et al., Detecting ALK, ROS1 and RET fusion genes in cell block samples, Transl. Oncol, vol.7, pp.363-367, 2014.

F. Zhao, Y. Han, Z. Liu, Z. Zhao, Z. Li et al., circFADS2 regulates lung cancer cells proliferation and invasion via acting as a sponge of mIR-498, Biosci. Rep, vol.38, p.20180570, 2018.

J. Zhao, L. Li, Q. Wang, H. Han, Q. Zhan et al., CircRNA expression profile in early-stage lung adenocarcinoma patients, Cell Physiol. Biochem, vol.44, pp.2138-2146, 2017.

Y. Zhou, X. Zheng, B. Xu, L. Chen, Q. Wang et al., , 2019.

, Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by mIR-1183/PDPK1 signaling pathway, Biochem. Biophys. Res. Commun, vol.508, pp.527-535

X. Zhu, L. , and J. , Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer, Oncotarget, vol.8, pp.97671-97682, 2017.

X. Zhu, X. Wang, S. Wei, Y. Chen, Y. Chen et al., hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma, FEBS J, vol.284, pp.2170-2182, 2017.

L. Zong, Q. Sun, H. Zhang, Z. Chen, Y. Deng et al., Increased expression of circRNA_102231 in lung cancer and its clinical significance, Biomed. Pharmacother, vol.102, pp.639-644, 2018.